Insider · CIK 0001721318
Katherine A. Eade
Files at HBIO (HARVARD BIOSCIENCE INC). First filing -, latest -.
In brief
Katherine A. Eade files SEC Form 4 as director at HBIO (HARVARD BIOSCIENCE INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Katherine A. Eade has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | HBIO HARVARD BIOSCIENCE INC | AGrant or award Common Stock | +16,556 | $0.00 | $0 | 58,669 | Jun 12, 2026 |
| Jul 16, 2025 | HBIO HARVARD BIOSCIENCE INC | AGrant or award Common Stock | +110,000 | $0.00 | $0 | 421,126 | Jul 18, 2025 |
Questions about Katherine A. Eade
Answered from the filings on this page, as of the latest one.
Is Katherine A. Eade buying or selling?
Katherine A. Eade has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Katherine A. Eade's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Katherine A. Eade has 0.
Where does Katherine A. Eade file Form 4?
Katherine A. Eade has filed Form 4 at HBIO (HARVARD BIOSCIENCE INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.